Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chro...
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe
About this item
Full title
Author / Creator
HEPVIR working group of the European Society for translational antiviral research (ESAR) , on behalf of the HEPVIR working group of the European Society for translational antiviral research (ESAR) , Colagrossi, Luna , Hermans, Lucas E , Salpini, Romina , Di Carlo, Domenico , Pas, Suzan D , Alvarez, Marta , Ben-Ari, Ziv , Boland, Greet , Bruzzone, Bianca , Coppola, Nicola , Seguin-Devaux, Carole , Dyda, Tomasz , Garcia, Federico , Kaiser, Rolf , Köse, Sukran , Krarup, Henrik , Lazarevic, Ivana , Lunar, Maja M , Maylin, Sarah , Micheli, Valeria , Mor, Orna , Paraschiv, Simona , Paraskevis, Dimitros , Poljak, Mario , Puchhammer-Stöckl, Elisabeth , Simon, François , Stanojevic, Maja , Stene-Johansen, Kathrine , Tihic, Nijaz , Trimoulet, Pascale , Verheyen, Jens , Vince, Adriana , Lepej, Snjezana Zidovec , Weis, Nina , Yalcinkaya, Tülay , Boucher, Charles A B , Wensing, Annemarie M J , Perno, Carlo F and Svicher, Valentina
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
HBsAg immune-escape mutations can favor HBV-transmission also in vaccinated individuals, promote immunosuppression-driven HBV-reactivation, and increase fitness of drug-resistant strains. Stop-codons can enhance HBV oncogenic-properties. Furthermore, as a consequence of the overlapping structure of HBV genome, some immune-escape mutations or stop-c...
Alternative Titles
Full title
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe
Authors, Artists and Contributors
Author / Creator
on behalf of the HEPVIR working group of the European Society for translational antiviral research (ESAR)
Colagrossi, Luna
Hermans, Lucas E
Salpini, Romina
Di Carlo, Domenico
Pas, Suzan D
Alvarez, Marta
Ben-Ari, Ziv
Boland, Greet
Bruzzone, Bianca
Coppola, Nicola
Seguin-Devaux, Carole
Dyda, Tomasz
Garcia, Federico
Kaiser, Rolf
Köse, Sukran
Krarup, Henrik
Lazarevic, Ivana
Lunar, Maja M
Maylin, Sarah
Micheli, Valeria
Mor, Orna
Paraschiv, Simona
Paraskevis, Dimitros
Poljak, Mario
Puchhammer-Stöckl, Elisabeth
Simon, François
Stanojevic, Maja
Stene-Johansen, Kathrine
Tihic, Nijaz
Trimoulet, Pascale
Verheyen, Jens
Vince, Adriana
Lepej, Snjezana Zidovec
Weis, Nina
Yalcinkaya, Tülay
Boucher, Charles A B
Wensing, Annemarie M J
Perno, Carlo F
Svicher, Valentina
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_162243061cbc414bb1ca08196034caa5
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_162243061cbc414bb1ca08196034caa5
Other Identifiers
ISSN
1471-2334
E-ISSN
1471-2334
DOI
10.1186/s12879-018-3161-2
